世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Proteinase Kの市場規模、シェア、動向分析レポート：形態別（粉末、液体）、治療領域別（感染症、神経、腫瘍）、用途別、最終用途別、地域別、およびセグメント予測、2022年～2030年


Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology), By Application, By End Use, By Region, And Segment Forecasts, 2022 - 2030

プロティナーゼK市場の成長とトレンド Grand View Research, Inc.の新しいレポートによると、プロテイナーゼKの世界市場規模は2030年までに78億4000万米ドルに達し、2022年から2030年までCAGR8.84%で拡大する... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ 		2022年10月12日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら 		150 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

プロティナーゼK市場の成長とトレンド

Grand View Research, Inc.の新しいレポートによると、プロテイナーゼKの世界市場規模は2030年までに78億4000万米ドルに達し、2022年から2030年までCAGR8.84%で拡大すると予測されています。市場の成長は、分子診断技術やそれに関連するIVD用酵素の幅広い用途によって促進されています。Proteinase Kは、PCRやNGSの補助として活用することができます。遺伝子発現プロファイリングとqPCRによる標的パネルが、病理学研究室におけるNGS配列の最も頻繁な用途の2つであることに変わりはありません。さらに、NGSシーケンスの価格低下により、NSC技術の利用が拡大しています。したがって、NGS診断技術に対する需要の高まりは、市場の成長を後押しすると予想されます。

さらに、細胞分離手順の採用が増加していることも、市場成長に寄与する大きな要因の1つです。企業は、市場での競争力を高めるために、持続可能な技術の構築に着手しています。例えば、2022年4月、Levitas Bio社は、既存の細胞分離用プラットフォームの次世代版を発表しました。新バージョンは、研究者の実験を最大16倍まで拡大し、1回の実行で約4000万個の細胞を処理することを支援することが期待される。

さらに、POCベースの診断薬の利用が世界的に大幅に増加しています。感染症の症状や予防法を特定することを目的とした国民の意識向上キャンペーンは、病気の感染を抑制する上で重要な役割を担っています。このように、患者の関心が高まることで、POCの需要も高まっています。例えば、2020年5月、Specific High Sensitivity Enzymatic Reporter UnLOCKing（SHERLOCK）診断によるCOVID-19のPOC検査に関する研究が発表されました。研究者は、Proteinase Kを含むLucigen社のQuickExtractを使用しました。このように、POC診断の需要の高まりとPOC診断検査におけるProteinase Kの有用性は、市場成長を促進すると予想されます。

さらに、分子生物学やその他の分野でのプロテイナーゼKの用途が拡大していることから、近い将来、有利な機会を生み出すと期待されています。プロテイナーゼKは、食品・飲料業界において品質基準を維持するために使用されています。食品メーカーは、製造に使用する原材料の品質維持に努めています。さらに、プロテイナーゼKは、加工食品からDNAを抽出する際の細胞溶解にも使用されます。また、分子生物学的な分析にも幅広く利用されています。したがって、プロテイナーゼKのこのような用途は、予測期間中、市場を牽引すると予想されます。

プロティナーゼK市場のレポートハイライト

- 形態別では、2021年に粉末セグメントが圧倒的なシェアを占めています。粉末形態の利点は、長い保存期間、安価な出荷、高い安定性などです。したがって、このような利点により、粉末の採用が増加すると予想される

- 治療分野別では、感染症分野が2021年に最大のシェアを占めた。低・中所得国における感染症の発生率の増加とともに、迅速分子検査におけるプロテイナーゼKの存在が、低リソース環境での操作が容易な製品の開発をプレーヤーに促すと予想されます。このことが、市場の成長を加速させています。

- アプリケーション別では、ゲノムDNAおよびRNAの分離・精製セグメントが2021年に最大のシェアを占めた。がんや希少疾患における個別化治療のニーズが高まっていることから、DNAやRNAの分離の需要は増加傾向にあると予想され、同様の傾向は市場にも反映されると考えられる

- 最終用途別では、2021年にバイオテクノロジー企業が主要な収益シェアを占めています。これは、バイオテクノロジー企業の臨床および前臨床研究をサポートするためのIn Situ Hybridization（ISH）技術の適用が増加したためである

- 北米は2021年に最大の市場シェアを占め、プロテイナーゼKの高い需要と地域における感染症の流行増加により、予測期間中もそのリードを維持すると予想される

- アジア太平洋地域は、ゲノム研究を促進するための政府の様々な取り組みと、シーケンシング技術の用途の増加により、将来的に大きく成長すると予測されています。



ページTOPに戻る


目次

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1.1 Secondary Data Sources
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Global Market: CAGR Calculation
1.7 Objectives
1.7.1 Objective 1
1.7.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Market Segmentation
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.1.1 Ivd Market
3.1.1.2 Molecular Biology Enzymes And Kits Market
3.1.2 Related/Ancillary Market Outlook
3.2 Impact of COVID-19 Pandemic on Proteinase K Market
3.3 Penetration & Growth Prospect Mapping
3.4 Proteinase K Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Broad Applications Of Molecular Diagnostic Techniques And Their Associated Enzymes For Ivd
3.4.1.2 Rise In Demand For Poc Diagnostics And Utility Of Proteinase K In Poc Diagnostic Tests
3.4.1.3 Increasing Adoption Of Cell Separation Technique
3.4.2 Market Restraint Analysis
3.4.2.1 Reimbursement Challenges Associated With Diagnostic Tests
3.4.3 Market Opportunity Analysis
3.4.3.1 Applications Of Proteinase K In Molecular Biology And Other Fields
3.4.4 Market Challenge Analysis
3.4.4.1 Challenges Associated With Purification & Recovery Of Enzymes
3.5 Proteinase K Market Industry Analysis
3.5.1 Porter’s
3.5.2 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 Joint Ventures
3.6.2 Mergers & Acquisitions
3.6.3 Licensing & Partnership
3.6.4 Technology Collaborations
3.6.5 Strategic Divestments
Chapter 4 Form Business Analysis
4.1 Form Movement Analysis & Market Share, 2021 & 2030
4.2 Market Size & Forecasts and Trend Analysis, 2018 to 2030
4.3 Powder
4.3.1 Global proteinase K market for powder form, 2018 - 2030 (USD Million)
4.4 Liquid
4.4.1 Global proteinase K market for liquid form, 2018 - 2030 (USD Million)
Chapter 5 Therapeutic Area Business Analysis
5.1 Therapeutic Area Movement Analysis & Market Share, 2021 & 2030
5.2 Infectious diseases
5.2.1 Global proteinase K market for infectious diseases, 2018 - 2030 (USD Million)
5.3 Diabetes
5.3.1 Global proteinase K market for diabetes, 2018 - 2030 (USD Million)
5.4 Oncology
5.4.1 Global proteinase K market for oncology, 2018 - 2030 (USD Million)
5.5 Cardiology
5.5.1 Global proteinase K market for cardiology, 2018 - 2030 (USD Million)
5.6 Nephrology
5.6.1 Global proteinase K market for nephrology, 2018 - 2030 (USD Million)
5.7 Autoimmune Diseases
5.7.1 Global proteinase K market for autoimmune diseases, 2018 - 2030 (USD Million)
5.8 Neurology
5.8.1 Global proteinase K market for neurology, 2018 - 2030 (USD Million)
5.9 Others
5.9.1 Global proteinase K market for others, 2018 - 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Application Movement Analysis & Market Share, 2021 & 2030
6.2 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.3 Isolation and Purification of Genomic DNA & RNA
6.3.1 Global proteinase K market for isolation and purification of genomic DNA & RNA, 2018 - 2030 (USD Million)
6.4 In Situ Hybridization
6.4.1 Global proteinase K market for ISH market, 2018 - 2030 (USD Million)
6.5 Mitochondria isolation
6.5.1 Global proteinase K market for mitochondria isolation market, 2018 - 2030 (USD Million)
Chapter 7 End-Use Business Analysis
7.1 End-Use Movement Analysis and Market Share, 2021 & 2030
7.1.1 Biotechnology Companies
7.1.1.1 Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.2 Diagnostic Laboratories
7.1.2.1 Diagnostic Laboratories Market Estimates & Forecasts, 2018 - 2030 (USD Million)
7.1.3 Cros
7.1.3.1 Cros Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.4 Academic Institutes
7.1.4.1 Academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Regional Business Analysis
8.1 Proteinase K Market Share by Regional, 2021 & 2030
8.2 North America
8.2.1 North America Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Germany Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Australia Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4.6 Singapore
8.4.6.1 Singapore Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 Mea Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 Competitive Analysis
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.2 Company Market Share, 2021
9.3 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
9.4 Vendor Landscape
9.4.1 Public Companies
9.4.2 Private Companies
Chapter 10 Competitive Landscape
10.1.1 MERCK KGAA
10.1.1.1 Company Overview
10.1.1.2 Sigma-Aldrich Co. LLC
10.1.1.2.1 Company Overview
10.1.1.3 Financial Performance
10.1.1.4 Product Benchmarking
10.1.1.5 Strategic Initiatives
10.1.2 QIAGEN
10.1.2.1 Company Overview
10.1.2.2 Financial Performance
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 THERMO FISHER SCIENTIFIC, INC.
10.1.3.1 Company Overview
10.1.3.2 Financial Performance
10.1.3.3 Product Benchmarking
10.1.3.4 Strategic Initiatives
10.1.4 F. HOFFMANN-LA ROCHE LTD.
10.1.4.1 Company Overview
10.1.4.2 Financial Performance
10.1.4.3 Product Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 ABCAM PLC
10.1.5.1 Company Overview
10.1.5.2 Financial Performance
10.1.5.3 Product Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 AGILENT TECHNOLOGIES, INC.
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 BIOCATALYSTS LTD.
10.1.7.1 Company Overview
10.1.7.2 Financial Performance
10.1.7.3 Product Benchmarking
10.1.7.4 Strategic Initiatives
10.1.8 MINERVA BIOLABS GMBH
10.1.8.1 Company Overview
10.1.8.2 Product Benchmarking
10.1.8.3 Strategic Initiatives
10.1.9 PROMEGA CORPORATION
10.1.9.1 Company Overview
10.1.9.2 Financial Performance
10.1.9.3 Product Benchmarking
10.1.9.4 Strategic Initiatives
10.1.10 TAKARA BIO, INC.
10.1.10.1 Company Overview
10.1.10.2 Financial Performance
10.1.10.3 Product Benchmarking
10.1.10.4 Strategic Initiatives
10.1.11 NEW ENGLAND BIOLABS
10.1.11.1 Company Overview
10.1.11.2 Product Benchmarking
10.1.11.3 Strategic Initiatives
10.1.12 MP BIOMEDICALS
10.1.12.1 Company Overview
10.1.12.2 Product Benchmarking
10.1.12.3 Strategic Initiatives

　

ページTOPに戻る


　

Summary

Proteinase K Market Growth & Trends

The global proteinase K market size is expected to reach USD 7.84 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.84% from 2022 to 2030. The market growth is fueled by a broad range of applications in molecular diagnostic techniques and their associated enzymes for IVD. Proteinase K can be utilized as a supplement in PCR and NGS. Increasing applications of NGS in personalized medicine along with various clinically developed therapies are likely to favor the market for proteinase K. Gene expression profiling and targeted panels via qPCR remain the two most frequent uses for NGS sequences in a pathology lab. In addition, a decline in the price of NGS sequencing has expanded the use of NSC technologies. Therefore, the growing demand for NGS diagnostic techniques is expected to boost the market growth.

In addition, the rising adoption of cell separation procedures is one of the major factors contributing to the market growth. Companies have initiated building sustainable technologies to gain a competitive edge in the market. For instance, in April 2022, Levitas Bio introduced the next generation of its existing platform for cell separation. The new version is expected to assist researchers in scaling their experiments up to 16X and process around 40 million cells per run.

Moreover, the usage of POC-based diagnostics is increasing significantly globally. Public awareness campaigns aimed at identifying the symptoms of infectious diseases and ways to prevent them play an important role in controlling disease transmission. Thus, increased patient attention has led to a rise in demand for POC. For instance, in May 2020, a study on POC testing for COVID-19 through Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) diagnostics was published. The researchers used QuickExtract by Lucigen, which contains Proteinase K. Thus, the growing demand for POC diagnostics and the utility of proteinase K in POC diagnostic tests are expected to fuel market growth.

Furthermore, growing applications of proteinase K in molecular biology and other fields are expected to create lucrative opportunities in the near future. Proteinase K is used in the food and beverage industry to maintain quality standards. Food manufacturers work to maintain the quality of raw materials used for manufacturing. In addition, proteinase K is used for cell lysis during DNA extraction from processed foods. The enzyme also finds application in a wide range of molecular biology assays. Hence, such applications of proteinase K are anticipated to drive the market during the forecast period.

Proteinase K Market Report Highlights

• By form, the powder segment accounted for a dominant share in 2021. Advantages of powder form include long shelf-life, inexpensive shipment, and high stability. Thus, such advantages are expected to increase the adoption of powder

• By therapeutic area, the infectious diseases segment captured the largest share in 2021. Presence of proteinase K in the rapid molecule testing along with increasing incidence of infectious diseases in low- to mid-income countries is anticipated to encourage players to develop products that are easy to operate in a low-resource setting. This is, in turn, accelerating the market growth

• By application, the isolation and purification of genomic DNA and RNA segment held the largest share in 2021. With the emerging need for personalized treatment in cancer and rare diseases, the demand for DNA or RNA isolation is anticipated to witness upward trends and similar trends will be reflected in the market

• By end-use, biotechnology companies held a leading revenue share in 2021. This is due to an increase in the application of In Situ Hybridization (ISH) techniques to support clinical and preclinical studies for biotechnology companies

• North America occupied the largest market share in 2021 and is expected to maintain its lead over the forecast period owing to the high demand for proteinase K and the increasing prevalence of infectious diseases in the region

• Asia Pacific is projected to grow considerably in the future owing to increasing applications of sequencing technology, coupled with various government initiatives to promote genomics research



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1.1 Secondary Data Sources
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Global Market: CAGR Calculation
1.7 Objectives
1.7.1 Objective 1
1.7.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Market Segmentation
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.1.1 Ivd Market
3.1.1.2 Molecular Biology Enzymes And Kits Market
3.1.2 Related/Ancillary Market Outlook
3.2 Impact of COVID-19 Pandemic on Proteinase K Market
3.3 Penetration & Growth Prospect Mapping
3.4 Proteinase K Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Broad Applications Of Molecular Diagnostic Techniques And Their Associated Enzymes For Ivd
3.4.1.2 Rise In Demand For Poc Diagnostics And Utility Of Proteinase K In Poc Diagnostic Tests
3.4.1.3 Increasing Adoption Of Cell Separation Technique
3.4.2 Market Restraint Analysis
3.4.2.1 Reimbursement Challenges Associated With Diagnostic Tests
3.4.3 Market Opportunity Analysis
3.4.3.1 Applications Of Proteinase K In Molecular Biology And Other Fields
3.4.4 Market Challenge Analysis
3.4.4.1 Challenges Associated With Purification & Recovery Of Enzymes
3.5 Proteinase K Market Industry Analysis
3.5.1 Porter’s
3.5.2 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 Joint Ventures
3.6.2 Mergers & Acquisitions
3.6.3 Licensing & Partnership
3.6.4 Technology Collaborations
3.6.5 Strategic Divestments
Chapter 4 Form Business Analysis
4.1 Form Movement Analysis & Market Share, 2021 & 2030
4.2 Market Size & Forecasts and Trend Analysis, 2018 to 2030
4.3 Powder
4.3.1 Global proteinase K market for powder form, 2018 - 2030 (USD Million)
4.4 Liquid
4.4.1 Global proteinase K market for liquid form, 2018 - 2030 (USD Million)
Chapter 5 Therapeutic Area Business Analysis
5.1 Therapeutic Area Movement Analysis & Market Share, 2021 & 2030
5.2 Infectious diseases
5.2.1 Global proteinase K market for infectious diseases, 2018 - 2030 (USD Million)
5.3 Diabetes
5.3.1 Global proteinase K market for diabetes, 2018 - 2030 (USD Million)
5.4 Oncology
5.4.1 Global proteinase K market for oncology, 2018 - 2030 (USD Million)
5.5 Cardiology
5.5.1 Global proteinase K market for cardiology, 2018 - 2030 (USD Million)
5.6 Nephrology
5.6.1 Global proteinase K market for nephrology, 2018 - 2030 (USD Million)
5.7 Autoimmune Diseases
5.7.1 Global proteinase K market for autoimmune diseases, 2018 - 2030 (USD Million)
5.8 Neurology
5.8.1 Global proteinase K market for neurology, 2018 - 2030 (USD Million)
5.9 Others
5.9.1 Global proteinase K market for others, 2018 - 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Application Movement Analysis & Market Share, 2021 & 2030
6.2 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.3 Isolation and Purification of Genomic DNA & RNA
6.3.1 Global proteinase K market for isolation and purification of genomic DNA & RNA, 2018 - 2030 (USD Million)
6.4 In Situ Hybridization
6.4.1 Global proteinase K market for ISH market, 2018 - 2030 (USD Million)
6.5 Mitochondria isolation
6.5.1 Global proteinase K market for mitochondria isolation market, 2018 - 2030 (USD Million)
Chapter 7 End-Use Business Analysis
7.1 End-Use Movement Analysis and Market Share, 2021 & 2030
7.1.1 Biotechnology Companies
7.1.1.1 Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.2 Diagnostic Laboratories
7.1.2.1 Diagnostic Laboratories Market Estimates & Forecasts, 2018 - 2030 (USD Million)
7.1.3 Cros
7.1.3.1 Cros Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.4 Academic Institutes
7.1.4.1 Academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Regional Business Analysis
8.1 Proteinase K Market Share by Regional, 2021 & 2030
8.2 North America
8.2.1 North America Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Germany Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Australia Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4.6 Singapore
8.4.6.1 Singapore Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 Mea Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 Competitive Analysis
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.2 Company Market Share, 2021
9.3 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
9.4 Vendor Landscape
9.4.1 Public Companies
9.4.2 Private Companies
Chapter 10 Competitive Landscape
10.1.1 MERCK KGAA
10.1.1.1 Company Overview
10.1.1.2 Sigma-Aldrich Co. LLC
10.1.1.2.1 Company Overview
10.1.1.3 Financial Performance
10.1.1.4 Product Benchmarking
10.1.1.5 Strategic Initiatives
10.1.2 QIAGEN
10.1.2.1 Company Overview
10.1.2.2 Financial Performance
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 THERMO FISHER SCIENTIFIC, INC.
10.1.3.1 Company Overview
10.1.3.2 Financial Performance
10.1.3.3 Product Benchmarking
10.1.3.4 Strategic Initiatives
10.1.4 F. HOFFMANN-LA ROCHE LTD.
10.1.4.1 Company Overview
10.1.4.2 Financial Performance
10.1.4.3 Product Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 ABCAM PLC
10.1.5.1 Company Overview
10.1.5.2 Financial Performance
10.1.5.3 Product Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 AGILENT TECHNOLOGIES, INC.
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 BIOCATALYSTS LTD.
10.1.7.1 Company Overview
10.1.7.2 Financial Performance
10.1.7.3 Product Benchmarking
10.1.7.4 Strategic Initiatives
10.1.8 MINERVA BIOLABS GMBH
10.1.8.1 Company Overview
10.1.8.2 Product Benchmarking
10.1.8.3 Strategic Initiatives
10.1.9 PROMEGA CORPORATION
10.1.9.1 Company Overview
10.1.9.2 Financial Performance
10.1.9.3 Product Benchmarking
10.1.9.4 Strategic Initiatives
10.1.10 TAKARA BIO, INC.
10.1.10.1 Company Overview
10.1.10.2 Financial Performance
10.1.10.3 Product Benchmarking
10.1.10.4 Strategic Initiatives
10.1.11 NEW ENGLAND BIOLABS
10.1.11.1 Company Overview
10.1.11.2 Product Benchmarking
10.1.11.3 Strategic Initiatives
10.1.12 MP BIOMEDICALS
10.1.12.1 Company Overview
10.1.12.2 Product Benchmarking
10.1.12.3 Strategic Initiatives

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

Grand View Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/18　10:26

155.35 円

164.28 円

199.02 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.